Jennifer Amengual
Jennifer Amengual
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, post-transplant lymphoproliferative disease, viral infectious disease | Not yet recruiting | Phase 1 | 2026-09-17 | NCT07614282 | |
| Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-05-27 | NCT06954805 |